VS
stockvs
Go to ScreenerHub
AZN.L

AZN.L vs NVS

NVS

In the past 12 months, NVS returned +38% while AZN.L gained 21%.

AZN.L
AZN.L

AstraZeneca PLC

$14,364.00
-5.3%(1M)
Market Cap222.8B
Healthcare
Drug Manufacturers - General
GB
P/E Ratio29.12
ROE23.0%
P/B Ratio6.21
Dividend Yield1.6%
NVS
NVS

Novartis AG

$154.87
-6.8%(1M)
Market Cap299.4B
Healthcare
Drug Manufacturers - General
CH
P/E Ratio21.34
ROE32.8%
P/B Ratio6.48
Dividend Yield3.0%
Performance Comparison

Historical returns across multiple timeframes

AZN.L

AZN.L

AstraZeneca PLC

+20.7%

1Y Return

NVS

NVS

Novartis AG

+38.0%

1Y Return

AZN.L
AZN.L
NVS
NVS

Short Term

1M-6M

NVS
+11.3%

Medium Term

YTD-1Y

NVS
+24.9%

Long Term

3Y-10Y

AZN.L
+130.1%

Valuation

Compare price multiples and valuation ratios

AZN.L: 2NVS: 3
MetricAZN.LNVSWinner
P/E Ratio

Price to earnings ratio

29.1221.34NVS
Forward P/E

Forward price to earnings ratio

0.000.00Tie
P/S Ratio

Price to sales ratio

5.085.30AZN.L
P/B Ratio

Price to book ratio

6.216.48AZN.L
P/FCF Ratio

Price to free cash flow ratio

29.4617.78NVS
EV/EBITDA

Enterprise value to EBITDA

16.1614.15NVS
PEG Ratio

Price/earnings to growth ratio

0.000.00Tie

Profitability

Compare profit margins and returns on capital

AZN.L: 1NVS: 5
MetricAZN.LNVSWinner
Gross Margin

Gross profit margin

78.2%75.7%AZN.L
Operating Margin

Operating profit margin

23.3%31.2%NVS
Net Margin

Net profit margin

17.4%24.9%NVS
ROE

Return on equity

23.0%32.8%NVS
ROA

Return on assets

9.1%12.1%NVS
ROIC

Return on invested capital

13.1%16.0%NVS

Growth

Compare revenue and earnings growth rates

AZN.L: 6NVS: 0
MetricAZN.LNVSWinner
Revenue Growth (YoY)

Year-over-year revenue growth

10.9%6.0%AZN.L
Revenue Growth (3Y)

3-year revenue CAGR

9.9%8.0%AZN.L
Revenue Growth (5Y)

5-year revenue CAGR

14.9%1.9%AZN.L
EPS Growth (YoY)

Year-over-year EPS growth

48.3%22.5%AZN.L
EPS Growth (3Y)

3-year EPS CAGR

46.0%31.4%AZN.L
EPS Growth (5Y)

5-year EPS CAGR

20.4%15.4%AZN.L

Balance Sheet & Risk

Compare financial stability and debt levels

AZN.L: 2NVS: 3
MetricAZN.LNVSWinner
Debt/Equity

Debt to equity ratio

0.610.80AZN.L
Current Ratio

Current assets to current liabilities

0.941.12NVS
Quick Ratio

Quick assets to current liabilities

0.720.89NVS
Interest Coverage

EBIT to interest expense

8.4315.13NVS
Beta

Stock volatility vs market

0.230.50AZN.L
Summary
NVS wins 3-1

Valuation

NVS

Profitability

NVS

Growth

AZN.L

Balance Sheet

NVS

NVS is more attractively valued. NVS shows stronger profitability. AZN.L demonstrates better growth. NVS has a stronger balance sheet.

Take Your Analysis Further

Dive deeper into AZN.L and NVS with Screenerhub. Access advanced screening tools, set up monitoring alerts, and discover more investment opportunities.

Embed This Comparison
Free

Add this comparison widget to your blog or website:

<a href="https://stockvs.app/AZN.L/vs/NVS" target="_blank" rel="noopener noreferrer" style="display: inline-flex; align-items: center; gap: 8px; padding: 8px 16px; background: linear-gradient(135deg, #3b82f6, #8b5cf6); color: white; text-decoration: none; border-radius: 8px; font-family: system-ui, sans-serif; font-size: 14px; font-weight: 500;">
  <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M18 20V10"/><path d="M12 20V4"/><path d="M6 20v-6"/></svg>
  Compare AZN.L vs NVS on stockvs.app
</a>